Danaher Corp. said its third-quarter 2018 adjusted net earnings per share were up 10% annually to $1.10 from $1 in the year-ago period.

The S&P Global Market Intelligence normalized EPS consensus estimate for the third quarter was $1.07.

The medical device maker said its revenues rose 7% annually to $4.85 billion from $4.53 billion in the same period of 2017.

On a GAAP basis, net earnings for the quarter totaled $663.7 million, or 93 cents per share, up from $572.1 million, or 81 cents per share, in the prior year period.

Revised 2018 outlook

The Washington, D.C.-based company raised its 2018 adjusted EPS guidance to a range of $4.49 to $4.52 from $4.43 to $4.50 previously.

The S&P Global Market Intelligence normalized EPS consensus estimate for 2018 is $4.49.

Danaher expects to post full-year GAAP EPS in the range of $3.72 to $3.75, up from the prior range of $3.64 to $3.71.